Executive Director of Safety
Iambic Therapeutics, Inc
Summary
The Executive Director of Safety will serve as the company's senior authority for drug safety and pharmacovigilance (PV), responsible for developing and executing global safety strategies across all clinical programs. This leader will report to the Chief Medical Officer (CMO) and will oversee safety science, signal management, and vendor/CRO oversight while building scalable processes that align with the company's growth trajectory. The successful candidate will lead a safety group that is integrated into the broader clinical development ecosystem rather than siloed as a separate function.
Job description
Job Summary
The Executive Director of Safety will serve as the company's senior authority for drug safety and pharmacovigilance (PV), responsible for developing and executing global safety strategies across all clinical programs. This leader will report to the Chief Medical Officer (CMO) and will oversee safety science, signal management, and vendor/CRO oversight while building scalable processes that align with the company's growth trajectory. The successful candidate will lead a safety group that is integrated into the broader clinical development ecosystem rather than siloed as a separate function.
The ideal candidate is a hands-on, scientifically grounded safety leader who can operate strategically and tactically; comfortable engaging with executive leadership, regulators, and external partners, while also helping shape the company's long-term safety function. The position may be based in our San Diego headquarters or remote.
Key Responsibilities
- Lead the company's global safety and pharmacovigilance function, ensuring compliance with regulatory standards and alignment with clinical and corporate objectives.
- Serve as the company's senior safety expert for all programs, providing leadership on benefit-risk evaluation, safety signal assessment, and regulatory safety strategy.
- Provide safety input into clinical protocols, ICFs, Investigator's Brochures, and regulatory submissions, including INDs, DSURs, and future NDA/MAA filings.
- Lead safety-related interactions with global regulatory authorities (e.g., FDA, EMA, MHRA, PMDA), including participation in agency meetings and preparation of responses to safety inquiries.
- Oversee and manage full-service CROs responsible for safety case management, ensuring quality, compliance, and scientific rigor.
- Develop and maintain safety governance policies and SOPs, appropriate for a growing global organization.
- Build and mentor a high-performing safety team, including internal staff and external consultants.
- Collaborate cross-functionally with Clinical Science, Clinical Operations, Quality, Regulatory Affairs, and Biometrics to ensure integrated safety strategies and consistent data interpretation.
- Support strategic growth initiatives, including due diligence and safety assessments for potential partnerships.
Qualifications
- M.D. (preferred) or Pharm.D. with extensive experience in drug safety and pharmacovigilance.
- Minimum 10 years of experience in clinical development and safety, with at least 4 years in a leadership role.
- Strong background in oncology drug development, preferably with small-molecule therapeutics.
- Demonstrated success in building or scaling a pharmacovigilance function within a growing biotech or mid-size company.
- Proven experience in CRO oversight for safety and operational activities.
- In-depth knowledge of global PV regulations, ICH guidelines, and regulatory expectations across development phases.
- Familiarity with safety databases (e.g., Argus, ArisG) and vendor qualification processes.
- Excellent communication and leadership skills, with the ability to influence internal and external stakeholders.
- Experience leading safety strategy through regulatory submissions and global filings preferred.
- Experience integrating safety systems and workflows in growth-stage environments preferred.
Requirements
- M.D. (preferred) or Pharm.D. with extensive experience in drug safety and pharmacovigilance
- Minimum 10 years of experience in clinical development and safety
- At least 4 years in a leadership role
- Strong background in oncology drug development, preferably with small-molecule therapeutics
- Demonstrated success in building or scaling a pharmacovigilance function within a growing biotech or mid-size company
- Proven experience in CRO oversight for safety and operational activities
- In-depth knowledge of global PV regulations, ICH guidelines, and regulatory expectations across development phases
- Familiarity with safety databases (e.g., Argus, ArisG) and vendor qualification processes
- Excellent communication and leadership skills, with the ability to influence internal and external stakeholders
- Experience leading safety strategy through regulatory submissions and global filings preferred
- Experience integrating safety systems and workflows in growth-stage environments preferred
Benefits
- Medical coverage
- Flexible spending accounts
- Voluntary life insurance
- 401(k) matching
- Flexible time off
Company overview
Iambic Therapeutics is a clinical-stage biotechnology company that leverages artificial intelligence to revolutionize drug discovery and development. Founded in 2019 and headquartered in San Diego, California, the company has developed a unique AI-driven platform that integrates physics-based algorithms with high-throughput experimental capabilities. Iambic's platform combines state-of-the-art technologies including NeuralPLexer for protein-ligand structure prediction, Enchant for clinical property prediction, and OrbNet for quantum chemistry acceleration. The company operates with a team of approximately 51-200 employees who bridge the gap between pioneering AI experts and experienced drug hunters. Iambic has demonstrated remarkable efficiency in advancing drug candidates to clinical trials, with its lead program IAM1363 already in Phase 1/1b studies for HER2-driven cancers. The company has raised over $300 million in funding and maintains strategic partnerships with pharmaceutical leaders like Lundbeck, focusing on addressing urgent unmet patient needs through innovative therapeutic approaches.